Literature DB >> 8193875

A critical appraisal of antiemetic prophylaxis: are we really making progress?

M Dicato.   

Abstract

Mesh：

Substances：

Year:  1993        PMID： 8193875     DOI： 10.1007/bf00366440

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN： 0941-4355            Impact factor:   3.603


× No keyword cloud information.
  3 in total

1.  Severe vascular adverse effects with thrombocytopenia and renal failure following emetogenic chemotherapy and ondansetron.

Authors:  A S Coates; A Childs; K Cox; C Forsyth; D E Joshua; E McNeil; J J Grygiel
Journal:  Ann Oncol       Date:  1992-11       Impact factor: 32.976

2.  Prevention of cisplatin-induced emesis: a double-blind multicenter randomized crossover study comparing ondansetron and ondansetron plus dexamethasone.

Authors:  F Roila; M Tonato; F Cognetti; E Cortesi; G Favalli; M Marangolo; D Amadori; M A Bella; V Gramazio; D Donati
Journal:  J Clin Oncol       Date:  1991-04       Impact factor: 44.544

3.  Antiemetic efficacy of high-dose metoclopramide: randomized trials with placebo and prochlorperazine in patients with chemotherapy-induced nausea and vomiting.

Authors:  R J Gralla; L M Itri; S E Pisko; A E Squillante; D P Kelsen; D W Braun; L A Bordin; T J Braun; C W Young
Journal:  N Engl J Med       Date:  1981-10-15       Impact factor: 91.245
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.